Literature DB >> 30021897

Hepatitis B Virus Deregulates the Cell Cycle To Promote Viral Replication and a Premalignant Phenotype.

Yuchen Xia1, Xiaoming Cheng1, Yao Li1,2, Kristin Valdez1, Weiping Chen3, T Jake Liang4.   

Abstract

Hepatitis B virus (HBV) infection is a major health problem worldwide, and chronically infected individuals are at high risk of developing cirrhosis and hepatocellular carcinoma (HCC). The molecular mechanisms whereby HBV causes HCC are largely unknown. Using a biologically relevant system of HBV infection of primary human hepatocytes (PHHs), we studied how HBV perturbs gene expression and signaling pathways of infected hepatocytes and whether these effects are relevant to productive HBV infection and HBV-associated HCC. Using a human growth factor antibody array, we first showed that HBV infection induced a distinct profile of growth factor production by PHHs, marked particularly by significantly lower levels of the transforming growth factor β (TGF-β) family of proteins in the supernatant. Transcriptome profiling next revealed multiple changes in cell proliferation and cell cycle control pathways in response to HBV infection. A human cell cycle PCR array validated deregulation of more than 20 genes associated with the cell cycle in HBV-infected PHHs. Cell cycle analysis demonstrated that HBV-infected PHHs are enriched in the G2/M phase compared to the predominantly G0/G1 phase of cultured PHHs. HBV proviral host factors, such as PPARA, RXRA, and CEBPB, were upregulated upon HBV infection and particularly enriched in cells in the G2/M phase. Together, these results support the notion that HBV deregulates cell cycle control to render a cellular environment that is favorable for productive HBV infection. By perturbing cell cycle regulation of infected cells, HBV may coincidently induce a premalignant phenotype that predisposes infected hepatocytes to subsequent malignant transformation.IMPORTANCE Hepatitis B virus (HBV) infection is a major health problem with high risk of developing hepatocellular carcinoma (HCC). By using a biologically relevant system of HBV infection of primary human hepatocytes (PHHs), we studied how HBV perturbs gene expression and whether these effects are relevant to HBV-associated HCC. HBV induced a distinct profile of growth factor production, marked particularly by significantly lower levels of the transforming growth factor β (TGF-β) family of proteins. Transcriptome profiling revealed multiple changes in cell proliferation and cell cycle control pathways. Cell cycle analysis demonstrated that HBV-infected PHHs are enriched in the G2/M phase. HBV proviral host factors were upregulated upon infection and particularly enriched in cells in the G2/M phase. Together, these results support the notion that HBV deregulates cell cycle control to render a cellular environment that is favorable for productive infection. This may coincidently induce a premalignant phenotype that predisposes infected hepatocytes to subsequent malignant transformation.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  cell cycle; hepatitis B virus; hepatocellular carcinoma; primary human hepatocytes; transforming growth factor

Mesh:

Substances:

Year:  2018        PMID: 30021897      PMCID: PMC6146796          DOI: 10.1128/JVI.00722-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  67 in total

Review 1.  Cyclins and cell cycle checkpoints.

Authors:  D G Johnson; C L Walker
Journal:  Annu Rev Pharmacol Toxicol       Date:  1999       Impact factor: 13.820

2.  The human immunodeficiency virus Vpr protein binds Cdc25C: implications for G2 arrest.

Authors:  Wei Chun Goh; Nicolas Manel; Michael Emerman
Journal:  Virology       Date:  2004-01-05       Impact factor: 3.616

3.  Hepatitis B virus X protein activates the ATM-Chk2 pathway and delays cell cycle progression.

Authors:  Sujeong Kim; Ho-Soo Lee; Jae-Hoon Ji; Mi-Young Cho; Young-Suk Yoo; Yong-Yea Park; Hyuk-Jin Cha; Youngsoo Lee; Youngbae Kim; Hyeseong Cho
Journal:  J Gen Virol       Date:  2015-04-14       Impact factor: 3.891

4.  The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors.

Authors:  C Cayrol; E K Flemington
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

5.  Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo.

Authors:  Lena Allweiss; Tassilo Volz; Katja Giersch; Janine Kah; Giuseppina Raffa; Joerg Petersen; Ansgar W Lohse; Concetta Beninati; Teresa Pollicino; Stephan Urban; Marc Lütgehetmann; Maura Dandri
Journal:  Gut       Date:  2017-04-20       Impact factor: 23.059

6.  Association of tissue promoter methylation levels of APC, TGFβ2, HOXD3 and RASSF1A with prostate cancer progression.

Authors:  Liyang Liu; Ken J Kron; Vaijayanti V Pethe; Nino Demetrashvili; Michael E Nesbitt; John Trachtenberg; Hilmi Ozcelik; Neil E Fleshner; Laurent Briollais; Theodorus H van der Kwast; Bharati Bapat
Journal:  Int J Cancer       Date:  2011-04-13       Impact factor: 7.396

7.  Epigenetic suppression of the TGF-beta pathway revealed by transcriptome profiling in ovarian cancer.

Authors:  Noriomi Matsumura; Zhiqing Huang; Seiichi Mori; Tsukasa Baba; Shingo Fujii; Ikuo Konishi; Edwin S Iversen; Andrew Berchuck; Susan K Murphy
Journal:  Genome Res       Date:  2010-12-14       Impact factor: 9.043

8.  Hepatic differentiation of human pluripotent stem cells in miniaturized format suitable for high-throughput screen.

Authors:  Arnaud Carpentier; Ila Nimgaonkar; Virginia Chu; Yuchen Xia; Zongyi Hu; T Jake Liang
Journal:  Stem Cell Res       Date:  2016-03-29       Impact factor: 2.020

9.  Absence of viral interference and different susceptibility to interferon between hepatitis B virus and hepatitis C virus in human hepatocyte chimeric mice.

Authors:  Nobuhiko Hiraga; Michio Imamura; Tsuyoshi Hatakeyama; Shosuke Kitamura; Fukiko Mitsui; Shinji Tanaka; Masataka Tsuge; Shoichi Takahashi; Hiromi Abe; Toshiro Maekawa; Hidenori Ochi; Chise Tateno; Katsutoshi Yoshizato; Takaji Wakita; Kazuaki Chayama
Journal:  J Hepatol       Date:  2009-09-23       Impact factor: 25.083

10.  Transforming growth factor-β1 suppresses hepatitis B virus replication by the reduction of hepatocyte nuclear factor-4α expression.

Authors:  Ming-Hsiang Hong; Yu-Chi Chou; Yi-Chieh Wu; Kuen-Nan Tsai; Cheng-po Hu; King-Song Jeng; Mong-Liang Chen; Chungming Chang
Journal:  PLoS One       Date:  2012-01-20       Impact factor: 3.240

View more
  21 in total

1.  Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfection.

Authors:  Xiaoming Cheng; Takuro Uchida; Yuchen Xia; Regina Umarova; Chun-Jen Liu; Pei-Jer Chen; Anuj Gaggar; Vithika Suri; Marcus M Mücke; Johannes Vermehren; Stefan Zeuzem; Yuji Teraoka; Mitsutaka Osawa; Hiroshi Aikata; Keiji Tsuji; Nami Mori; Shuhei Hige; Yoshiyasu Karino; Michio Imamura; Kazuaki Chayama; T Jake Liang
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

2.  Blocking neddylation elicits antiviral effect against hepatitis B virus replication.

Authors:  Karima Abounouh; Mohammad Enamul Hoque Kayesh; Haya Altawalah; Bouchra Kitab; Shuko Murakami; Shintaro Ogawa; Yasuhito Tanaka; Hind Dehbi; Pascal Pineau; Michinori Kohara; Soumaya Benjelloun; Kyoko Tsukiyama-Kohara; Sayeh Ezzikouri
Journal:  Mol Biol Rep       Date:  2021-10-30       Impact factor: 2.316

3.  Histone Deacetylase Inhibitors Romidepsin and Vorinostat Promote Hepatitis B Virus Replication by Inducing Cell Cycle Arrest.

Authors:  Yang Yang; Yu Yan; Zhen Chen; Jie Hu; Kai Wang; Ni Tang; Xiaosong Li; Zhi Zhou
Journal:  J Clin Transl Hepatol       Date:  2021-03-08

Review 4.  The Role of Glypican-3 in Regulating Wnt, YAP, and Hedgehog in Liver Cancer.

Authors:  Aarti Kolluri; Mitchell Ho
Journal:  Front Oncol       Date:  2019-08-02       Impact factor: 6.244

5.  A Novel lncRNA IHS Promotes Tumor Proliferation and Metastasis in HCC by Regulating the ERK- and AKT/GSK-3β-Signaling Pathways.

Authors:  Zheng Chen; Wei Yu; Qiming Zhou; Jianlong Zhang; Hai Jiang; Dake Hao; Jie Wang; Zhenyu Zhou; Chuanchao He; Zhiyu Xiao
Journal:  Mol Ther Nucleic Acids       Date:  2019-04-30

6.  A dual role for SAMHD1 in regulating HBV cccDNA and RT-dependent particle genesis.

Authors:  Peter Ac Wing; Tamara Davenne; Jochen Wettengel; Alvina G Lai; Xiaodong Zhuang; Anindita Chakraborty; Valentina D'Arienzo; Catharina Kramer; Chunkyu Ko; James M Harris; Sabrina Schreiner; Martin Higgs; Stephanie Roessler; Joanna L Parish; Ulrike Protzer; Peter Balfe; Jan Rehwinkel; Jane A McKeating
Journal:  Life Sci Alliance       Date:  2019-03-27

7.  Integrated analysis of lncRNA-associated ceRNA network reveals potential biomarkers for the prognosis of hepatitis B virus-related hepatocellular carcinoma.

Authors:  Hongyan Li; Xiaonan Zhao; Chenghua Li; Chuanlun Sheng; Zhenzi Bai
Journal:  Cancer Manag Res       Date:  2019-01-17       Impact factor: 3.989

8.  Orchestration of Intracellular Circuits by G Protein-Coupled Receptor 39 for Hepatitis B Virus Proliferation.

Authors:  Kaku Goto; Hironori Nishitsuji; Masaya Sugiyama; Nao Nishida; Masashi Mizokami; Kunitada Shimotohno
Journal:  Int J Mol Sci       Date:  2020-08-07       Impact factor: 5.923

Review 9.  Multiple Roles for Hepatitis B and C Viruses and the Host in the Development of Hepatocellular Carcinoma.

Authors:  Kirk J Wangensteen; Kyong-Mi Chang
Journal:  Hepatology       Date:  2020-11-07       Impact factor: 17.425

10.  A genome-wide gain-of-function screen identifies CDKN2C as a HBV host factor.

Authors:  Carla Eller; Laura Heydmann; Che C Colpitts; Houssein El Saghire; Federica Piccioni; Frank Jühling; Karim Majzoub; Caroline Pons; Charlotte Bach; Julie Lucifora; Joachim Lupberger; Michael Nassal; Glenn S Cowley; Naoto Fujiwara; Sen-Yung Hsieh; Yujin Hoshida; Emanuele Felli; Patrick Pessaux; Camille Sureau; Catherine Schuster; David E Root; Eloi R Verrier; Thomas F Baumert
Journal:  Nat Commun       Date:  2020-06-01       Impact factor: 17.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.